American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,308 | 95,106 | 92,916 | 97,537 | 98,997 |
| Receivables | 46,865 | 119,023 | 80,126 | 66,768 | 53,504 |
| Inventories | 25,138 | 12,475 | 18,028 | 19,017 | 19,839 |
| Income taxes - deferred | 440 | 650 | 799 | 551 | 590 |
| Other current assets | 20,109 | 17,376 | 9,350 | 7,285 | 7,021 |
| TOTAL | $204,861 | $244,629 | $201,220 | $191,157 | $179,950 |
| Non-Current Assets | |||||
| PPE Net | 108,907 | 132,064 | 106,587 | 95,446 | 94,615 |
| Investments And Advances | 58,933 | 19,179 | 58,327 | 57,441 | 57,461 |
| Intangibles | 202,871 | 203,487 | 203,015 | 202,088 | 203,450 |
| Other Non-Current Assets | 39,041 | 10,865 | 34,990 | 40,259 | 41,236 |
| TOTAL | $409,753 | $365,595 | $402,917 | $395,234 | $396,762 |
| Total Assets | $614,614 | $610,223 | $604,137 | $586,391 | $576,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 62 | 61 | 61 | 61 | 60 |
| Accounts payable and accrued liabilities | 25,359 | 35,040 | 33,480 | 28,413 | 25,596 |
| Other current liabilities | 5,881 | N/A | 4,657 | 4,843 | 3,140 |
| TOTAL | $41,963 | $44,077 | $47,247 | $44,157 | $43,004 |
| Non-Current Liabilities | |||||
| Long Term Debt | 664 | N/A | 698 | 711 | 728 |
| Other Non-Current Liabilities | 120,549 | 121,064 | 119,467 | 118,878 | 118,306 |
| TOTAL | $136,872 | $137,573 | $135,919 | $135,235 | $134,766 |
| Total Liabilities | $178,834 | $181,650 | $183,166 | $179,392 | $177,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78 | 79 | 79 | 79 | 78 |
| Common Shares | 514 | 429 | 345 | 260 | 563 |
| Retained earnings | 208,439 | 205,261 | 204,752 | 199,421 | 194,297 |
| Other shareholders' equity | 22,762 | 19,560 | 13,291 | 5,509 | 3,672 |
| TOTAL | $435,779 | $428,573 | $420,971 | $406,998 | $398,942 |
| Total Liabilities And Equity | $614,614 | $610,223 | $604,137 | $586,391 | $576,712 |